Literature DB >> 30023150

Chikungunya virus: genomic microevolution in Eastern India and its in-silico epitope prediction.

Sudip Kumar Dutta1, Tamanash Bhattacharya1,2, Anusri Tripathi1.   

Abstract

This is the first study reporting whole genome sequences of two CHIKV strains (KJ679577 and KJ679578) isolated from Eastern Indian patients sera during 2010-2011 outbreak, both of which were of ECSA genotype, but from different subgroups: Indian Ocean outbreak and ECSA subtypes. Furthermore, viral sequences were analyzed using different in-silico approaches to identify potential genetic variations that might have functional implications on various aspects of virus replication, viral protein functionality, immunogenicity and transmission. Epitope prediction analysis revealed 70.9% increase in number of MHC Class-II interacting epitopes of KJ679578 and 25-28% increase in Class-I interacting epitopes of KJ679577 and KJ679578 compared to that of EF027141 (CHIKV of Asian genotype circulating in India during 1973, after which CHIKV infection disappeared from India for three decades). CHIKV peptides DLAKLAFKRSSKYDLECAQIPVHMKSDA and KVVLCGDPKQCGFFNMMQMKYNYNHNI were predicted to interact with maximum number of HLA Class-I (68 and 76.5%, respectively) and Class-II (47 and 100%, respectively) alleles present within Indian population with allele frequency of > 0.1 and were also recognized as predicted B-cell epitopes with BCPred score between 0.766 and 0.961 and with antigenicity ranging from 0.52 to 1.69; thus these peptides might be used to induce T- and B-cell-mediated immunity against CHIKV. Thus, the present study might help to bridge the gap between virus microevolution and its implication in host immunity by taking into account viral genetic and conformational changes. Predicted epitopes might be used as promising targets for peptide-based vaccine development and rapid diagnostics against CHIKV infection.

Entities:  

Keywords:  Chikungunya; Disease severity; Epitope; Genome sequencing; Substitution rate

Year:  2018        PMID: 30023150      PMCID: PMC6045979          DOI: 10.1007/s13205-018-1339-3

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  25 in total

1.  EMBOSS: the European Molecular Biology Open Software Suite.

Authors:  P Rice; I Longden; A Bleasby
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

2.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

3.  jModelTest 2: more models, new heuristics and parallel computing.

Authors:  Diego Darriba; Guillermo L Taboada; Ramón Doallo; David Posada
Journal:  Nat Methods       Date:  2012-07-30       Impact factor: 28.547

4.  A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.

Authors:  D N Bourdette; E Edmonds; C Smith; J D Bowen; C R G Guttmann; Z P Nagy; J Simon; R Whitham; J Lovera; V Yadav; M Mass; L Spencer; N Culbertson; R M Bartholomew; G Theofan; J Milano; H Offner; A A Vandenbark
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

5.  Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.

Authors:  K L Knutson; K Schiffman; M L Disis
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 6.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

7.  KoBaMIN: a knowledge-based minimization web server for protein structure refinement.

Authors:  João P G L M Rodrigues; Michael Levitt; Gaurav Chopra
Journal:  Nucleic Acids Res       Date:  2012-05-07       Impact factor: 16.971

8.  Structure prediction and analysis of MxaF from obligate, facultative and restricted facultative methylobacterium.

Authors:  Raghvendra Pratap Singh; Ram Nageena Singh; Manish K Srivastava; Alok Kumar Srivastava; Sudheer Kumar; Ramesh Chandra Dubey; Arun Kumar Sharma
Journal:  Bioinformation       Date:  2012-10-31

9.  Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.

Authors:  Yiu-Wing Kam; Fok-Moon Lum; Teck-Hui Teo; Wendy W L Lee; Diane Simarmata; Sumitro Harjanto; Chong-Long Chua; Yoke-Fun Chan; Jin-Kiat Wee; Angela Chow; Raymond T P Lin; Yee-Sin Leo; Roger Le Grand; I-Ching Sam; Joo-Chuan Tong; Pierre Roques; Karl-Heinz Wiesmüller; Laurent Rénia; Olaf Rötzschke; Lisa F P Ng
Journal:  EMBO Mol Med       Date:  2012-03-05       Impact factor: 12.137

10.  Comparative analysis of the genome sequences and replication profiles of chikungunya virus isolates within the East, Central and South African (ECSA) lineage.

Authors:  Karen Caiyun Chen; Yiu-Wing Kam; Raymond Tzer Pin Lin; Mary Mah-Lee Ng; Lisa Fp Ng; Justin Jang Hann Chu
Journal:  Virol J       Date:  2013-05-30       Impact factor: 4.099

View more
  3 in total

1.  In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.

Authors:  Sudip Kumar Dutta; Siddhartha Sengupta; Anusri Tripathi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-04-05       Impact factor: 2.416

2.  Source-tracking of the Chinese Chikungunya viruses suggests that Indian subcontinent and Southeast Asia act as major hubs for the recent global spread of Chikungunya virus.

Authors:  Shaofu Qiu; Jinpeng Guo; Peihan Li; Peng Li; Xinying Du; Rongzhang Hao; Chaojie Yang; Qi Wang; Hongbo Liu; Haoran Zhang; Sai Tian; Hua Shi; Liang Wen; Daizhi An; Xiaocui Yang; Xiaoyuan An; Ligui Wang; Changjun Wang; Hongbin Song
Journal:  Virol J       Date:  2021-10-11       Impact factor: 4.099

Review 3.  Adult Immunization - Need of the Hour.

Authors:  Abhishek Jairaj; P Shirisha; Muqthadir Siddiqui Mohammad Abdul; Urooj Fatima; Rahul Vinay Chandra Tiwari; Muhamood Moothedath
Journal:  J Int Soc Prev Community Dent       Date:  2018-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.